Five medical organizations this week released a toolkit for clinicians in post-acute and long-term care settings about the benefits of the COVID-19 bivalent booster and oral antiviral therapeutics. 

“This fall we are facing the possibility of a so-called ‘tripledemic’ featuring COVID-19, RSV, and the flu,” said Christopher Laxton, executive director of AMDA – The Society for Post-Acute and Long-Term Care Medicine. “At the same time, we see new COVID variants increasing in prevalence and able to evade some of our key therapeutics. That means it’s more important than ever to make sure everyone is protected.”

AMDA developed the toolkit with the American Society of Consultant Pharmacists, American Association of Nurse Practitioners, American Academy of Physician Associates, and Gerontological Advanced Practice Nurses Association.

Related News Articles

Headline
Between Oct. 10, 2022, and Jan. 8, 2023, nursing home residents who were not up to date with the recommended COVID-19 vaccinations had a 30%-50% higher risk…
Headline
The Centers for Disease Control and Prevention yesterday launched a website to help consumers locate no-cost COVID-19 testing through its Increasing…
Headline
In an online survey last November of 1,200 U.S. adults previously vaccinated against COVID-19, 62% had not yet received a bivalent booster dose, most often…
Headline
The Federal Emergency Management Agency this week simplified procedures for its Public Assistance Program, which provides disaster response grants to non-…
Perspective
The convening of the 118th Congress this week is a reminder of Washington’s highly-charged political environment. The once-in-a-century floor tussle over the…
Perspective
As Congress convenes for its post-election lame-duck session, we are turning up the pressure to secure additional support for hospitals and the patients and…